Results 1 - 10 of 772

< 1 2 3 ... 77 78 >

• Morgan B. Drug development: A healthy pipeline., Nature

  [PubMed: 27191492]
  [DOI: 10.1038/533S116a]
  
• Miner PB Jr; Koltun WD; Wiener GJ; De La Portilla M; Prieto B; Shailubhai K; Layton MB; Barrow L; Magnus L; Griffin PH. A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation., The American journal of gastroenterology

  [DOI: 10.1038/ajg.2016.611]
  
• Voelker R. Relief for Chronic Constipation., JAMA

  [DOI: 10.1001/jama.2017.1065]
  
• Al-Salama ZT; Syed YY. Plecanatide: First Global Approval., Drugs

  [DOI: 10.1007/s40265-017-0718-0]
  
• Camilleri M. Guanylate cyclase C agonists: emerging gastrointestinal therapies and actions., Gastroenterology

  [DOI: 10.1053/j.gastro.2015.01.003]
  
• Jarmu? A; Zieli?ska M; Storr M; Fichna J. Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases., Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

  [DOI: 10.1111/nmo.12574]
  
• Corsetti M; Tack J. New pharmacological treatment options for chronic constipation., Expert opinion on pharmacotherapy

  [DOI: 10.1517/14656566.2014.900543]
  
• Busby RW; Ortiz S. Clarification of linaclotide pharmacology presented in a recent clinical study of plecanatide., Digestive diseases and sciences

  [DOI: 10.1007/s10620-013-2953-x]
  
• Quigley EM. Open channels for functional bowel disorders: guanylate cyclase C agonists in IBS and CC., Digestive diseases and sciences

  [DOI: 10.1007/s10620-013-2766-y]
  
• Shailubhai K; Comiskey S; Foss JA; Feng R; Barrow L; Comer GM; Jacob GS. Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses., Digestive diseases and sciences

  [DOI: 10.1007/s10620-013-2684-z]